Sernova Biotherapeutics (SEOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 04-2023 | 01-2023 | 10-2022 | 07-2022 | 04-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,798 | -8,015 | -18,970 | -12,599 | -8,192 |
| Depreciation Amortization | 159 | 107 | 342 | 251 | 162 |
| Accounts receivable | 318 | 532 | -152 | -147 | -129 |
| Other Working Capital | 985 | 1,952 | 2,289 | 336 | 781 |
| Other Operating Activity | 639 | -46 | 5,288 | 4,635 | 3,523 |
| Operating Cash Flow | $-10,697 | $-5,471 | $-11,203 | $-7,524 | $-3,854 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -66 | -72 | -256 | -241 | -238 |
| Sale Of Investment | 17,013 | 23,956 | -35,733 | -30,311 | N/A |
| Other Investing Activity | 0 | 0 | -10 | 0 | 0 |
| Investing Cash Flow | $16,947 | $23,884 | $-35,998 | $-30,552 | $-238 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 28,361 | 18,681 | 1,112 |
| Other Financing Activity | 315 | 305 | 120 | 76 | 111 |
| Financing Cash Flow | $315 | $305 | $28,481 | $18,757 | $1,222 |
| Beginning Cash Position | 2,783 | 3,776 | 21,653 | 21,664 | 22,001 |
| End Cash Position | 9,348 | 22,495 | 2,933 | 2,346 | 19,131 |
| Net Cash Flow | $6,565 | $18,719 | $-18,719 | $-19,318 | $-2,870 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,697 | -5,471 | -11,203 | -7,524 | -3,854 |
| Capital Expenditure | -66 | -72 | -256 | -241 | -238 |
| Free Cash Flow | -10,763 | -5,542 | -11,458 | -7,765 | -4,092 |